ZyVersa Therapeutics Announces Publication in Clinical Immunology Demonstrating Association Between Renal NLRP3 Inflammasome Activation and Lupus Nephritis Disease Activity

<p>Lupus Nephritis (“LN”) is characterized by inflammation in the kidney, protein leakage into the urine (“proteinuria”), and progressive kidney damage NLRP3 inflammasomes were extensively activated in the kidneys of LN patients, with higher levels of activation in patients with more severe forms of the disease Inflammasome activation was positively correlated with clinicopathological indices of LN […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/zyversa-therapeutics-announces-publication-in-clinical-immunology-demonstrating-association-between-renal-nlrp3-inflammasome-activation-and-lupus-nephritis-disease-activity/">ZyVersa Therapeutics Announces Publication in Clinical Immunology Demonstrating Association Between Renal NLRP3 Inflammasome Activation and Lupus Nephritis Disease Activity</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>